Goodwin Procter LLP advised Allogene Therapeutics, Inc. on the deal. Allogene Therapeutics, Inc. (Nasdaq: ALLO) announced its formation of Allogene Overland Biopharm, a joint venture with…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now